← Back
Data updated: Mar 10, 2026
PTS CONSULTING
Pharmaceuticals
PTS CONSULTING is a generic drug manufacturer with 2 FDA-approved products.
2020
Since
2
Drugs
-
Trials
9
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
TOLTERODINE TARTRATE 2025-08-21
Labeling
DOXEPIN HYDROCHLORIDE 2025-08-06
TOLTERODINE TARTRATE 2025-06-17
Labeling
DOXEPIN HYDROCHLORIDE 2024-08-27
Labeling
DOXEPIN HYDROCHLORIDE 2024-08-27
Labeling
TOLTERODINE TARTRATE 2024-08-27
DOXEPIN HYDROCHLORIDE 2024-07-25
DOXEPIN HYDROCHLORIDE 2024-07-23
Labeling
DOXEPIN HYDROCHLORIDE 2024-07-01
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (1)
Company Info
- First Approval
- 2020-01-24
- Latest
- 2023-08-21
- Applications
- 2